PROGRAM
Thursday 9th October 2025
| 0900 - 1215 | Workshop 1 - Artificial Intelligence in Medicine | David Naude & Daniel de Viana |
| 0900 - 1215 | Workshop 2 - Updates in Radiation Oncology Topics
| Philip Poortmans and Orit Kaidar-Person |
| 0900 - 1215 | Workshop 3 - Mastering Perforator Flaps in Breast Surgery: Principles, Techniques and Refinements Topics
| Ashutosh Kothari, Peter Barry, Farid Meybodi, Peter Chin |
| 0900 - 1215 | Workshop 4 (Communication) - Hearsay: Have you ever said that? An interactive workshop Details about this workshop can be found here | Lesley Fallowfield |
| 1215 - 1300 | Lunch - for Workshop Attendees | |
| 1215 - 1300 | POSTER DISPLAY - AUTHORS PRESENT | |
| 1300 | Conference Opening and Welcome to country | |
| 1315 - 1530 | Session 1 - Hot Topics & Controversies in 2025 Neoadjuvant systemic therapy and radiotherapy implications 2025 - what is the evidence? Do anthracyclines still have a place in early breast cancer treatment? What the HER2? Pushing the boundaries of breast conserving surgery The patient voice: unmet needs and realities of breast cancer treatment | Orit Kaidar-Person Matteo Lambertini Elena Provenzano Ashutosh Kothari Emily Duncan, BCNA Seat at the Table (SATT) Consumer Representative |
| 1600 - 1745 | Session 2 - Wellbeing and Communication KEYNOTE: When words matter: communicating with the well-informed patient Hormone replacement in breast cancer patients: a controversy revisited Effective communication with AI Lessons, losses and hope: a Medical Oncologist reflects Q&A panel | Lesley Fallowfield Rhea Liang Dawid Naude Nicholas Wilcken |
| 1745 - 1945 | Social Function - Welcome/Networking Event (Exhibition Area) |
Friday 10th October 2025
| 0715 - 830 | Industry Breakfast Session | |
| 0715 - 830 | Industry Breakfast Session | |
| 0845 - 1035 | Session 3 - Risk Assessment and screening strategies KEYNOTE: Talking about risk & uncertainty in genetic testing Next-Gen screening: a look at risk-stratified trials & protocols Is hormone therapy safe for high-risk women without breast cancer? Revolutionising BreastScreen: a year of live AI readings in NSW The Lancet Breast Cancer Commission - a roadmap for personalising breast cancer prevention Q&A panel | Lesley Fallowfield Nehmat Houssami Rhea Liang Matthew Warner-Smith Kelly Anne Phillips |
| 1100 - 1245 | Session 4 - The Neoadjuvant multidisciplinary approach to management of breast cancer - the complexities Case Study 1 - Timing, sequencing and surgery: a complex case of high-risk breast cancer Case Study 2 - Young and ER-Positive: navigating the challenges of endocrine therapy intolerance The pathological assessment of neoadjuvant treated breast cancer Preoperative endocrine therapy as a functional biomarker in ER+ breast cancer Q&A panel | Tivya Kulasegaran Tivya Kulasegaran Elena Provenzano Belinda Yeo Matteo Lambertini, Ash Kothari. Elena Provenzano, Philip Poortmans, Orit Kaidar-Person, Lesley Fallowfield, Belinda Yeo, Owen Ung, Cameron Snell |
| 1245 - 1345 | Lunch in Trade Area POSTER DISPLAY - AUTHORS PRESENT | |
| 1245 | ASBD AGM | |
| 1345 - 1530 | Session 5 Rapid fire - Abstracts and oral presentations KEYNOTE: The young premenopausal woman the issues facing fertility, survivorship, pregnancy and genetic implications Q & A 4 x 7 minute oral presentations Q & A 4 x 7 minute oral presentations Q & A | Matteo Lambertini |
| 1600 - 1730 | Session 6 - Innovation and Advances KEYNOTE: AI, Digital Biomarkers - integration of AI into breast cancer pathology Smarter Surgery: Strategies to lower re-excision rates Innovations in Imaging: The PET trial and next-generation PET modalities The therapeutic value of mainstream genetic testing Q&A panel | Elena Provenzano Ashutosh Kothari Remy Lim Annabel Goodwin |
| 1900 - 2300 | Conference Dinner - QT Hotel Sponsored by |
Saturday 11th October 2025
| 0715 - 830 | Industry Breakfast Session | |
| 0845 - 1030 | Session 7 - Concurrent Sessions 7A Surgery and Radiotherapy - Updates in Management Global trends in training and practice of Oncoplastic Breast Surgery Sentinel nobe mapping: options beyond Tc99 TAD talk: a practical review of Axillary De-escalation Debate: Management of residual nodal disease after NACT Q&A panel 7B Medical Oncology - Estrogen receptor positive disease De-escalation in early HER2+ and TNBC: opportunities for tailored treatment HER2 is only half the story: the critical role of ER in HER2+ breast cancer What's next? Evolving treatment strategies after CDK4/6 inhibition progression All CLEAR - a strategy aiming at zero deaths from breast cancer Redefining phase 1: a first step, not a final hope Q&A panel | Ashutosh Kothari Peter Barry Farid Meybodi For further surgery: Ashutosh Kothari For radiotherapy: Orit Kaidar-Person Belinda Yeo Nicholas Wilcken Matteo Lambertini Christine Chaffer Dhanusha Sabanathan |
| 1100 - 1245 | Session 8 - Survivorship KEYNOTE: Key learnings from a real-world survivorship clinic Managing long term toxicities - bone matters Managing long term toxicities - heart matters Lymphoedema & Musculoskeletal issues update Nutrition, diets and supplements - navigating the plethora of information Q&A panel | Kim Kerin-Ayres Mike Lin Matthew Burrage Louise Koelmeyer Rewa Keegan |
| 1245 - 1330 | Lunch in Trade Area POSTER DISPLAY - AUTHORS PRESENT | |
| 1330 - 1500 | Session 9 - The last word on controversies panel Are we overtreating the low-risk cancer? High breast density: what now? Fibroepithelial lesions and predicting behaviour Radiotherapy to implant reconstruction and after skin sparing mastectomy Last chance questions - ask before it's too late! | Philip Poortmans Nehmat Houssami Sandra O'Tooler Orit Kaidar-Person |
| 1515 | Conference Close | Peter Chin & Maree Colosimo |
*Times are subject to change
CONTACT US
Impact Events ABN 45 094 598 339
Address: Unit 24, Level 3, 2 Brandon Park Drive, Wheelers
Hill Victoria 3150 Australia
Phone: 1300 061 814 or +61 3 8657 4987 Email: info@impactevents.com.au